By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Certain Drugs Can Trigger or Slow Alzheimer’s Disease
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Certain Drugs Can Trigger or Slow Alzheimer’s Disease
Specialties

Certain Drugs Can Trigger or Slow Alzheimer’s Disease

Anthony Cirillo
Anthony Cirillo
Share
2 Min Read
alzheimer's drugs
SHARE
alzheimer's drugs
alzheimer's drugs
Good or Bad? Hmmm.

Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research.

A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid plaques build up in the brains of Alzheimer’s patients.
 
Of the screened drugs, 800 reduced amyloid beta content more than 10% in primary neurons from mice, the researchers found. About 240 drugs promoted amyloid beta.

While many classes of drugs were found to impact amyloid beta production, the researchers focused especially on those used to treat cardiovascular conditions. Certain blood pressure medications, such as propranolol (Inderal) and nicardipine (Cardene), reduced amyloid beta production, while drugs including furosemide (Lasix) had the opposite effect. Experiments with mice confirmed that some CV medications, particularly carvedilol (Coreg), hold promise as Alzheimer’s drugs.
 
“This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to [Alzheimer’s disease] as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population,” the researchers wrote.

Source: McKnight’s LTC

More Read

botox certification
Help Improve People’s Skin Health Via Botox Certification
How to Prevent COPD Exacerbations Without Medication
What Are the Safest Options When You Need an Abortion Pill
The Pros And Cons Of Finding Out Health Information With DNA Test Kits
The Financial Hardship of Cancer
TAGGED:Alzheimer's Disease
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

alzheimer's stress
GeriatricsSpecialtiesWellness

Stress and Alzheimer’s: Increased Risk

April 30, 2013

Costs Associated with Spinal Disorders and Treatment

July 6, 2011

Top Ten Medical Innovations: Cleveland Clinic Summit Takeaway

October 18, 2011
Image
DiagnosticsRadiology

Accessible HealthCare Drives Innovation for Siemens

November 28, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?